Pre-diabetes and COVID-19, could we be missing the silent killer?

Exp Biol Med (Maywood). 2021 Feb;246(4):369-370. doi: 10.1177/1535370220973451. Epub 2020 Nov 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / analysis
  • COVID-19 / pathology*
  • Comorbidity
  • Diabetes Mellitus, Type 2 / pathology*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin / therapeutic use
  • Prediabetic State / blood
  • Prediabetic State / drug therapy
  • Prediabetic State / pathology*
  • SARS-CoV-2

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Metformin